RABIES

This early-stage study tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check safety and how well the vaccines trigger an immune response. Participants received either the vaccine or a placebo, and researche…

This study tested the safety of a new rabies vaccine in 80 healthy people aged 10 to 60. Participants received the vaccine using one of two different dosing schedules. Researchers monitored for side effects for up to 6 months. The goal was to see if the vaccine is safe enough to …

This study tested a new drug called SYN023 to prevent rabies in adults who were bitten or exposed to animals like dogs, cats, or bats. 448 people took part and received either SYN023 or the standard rabies prevention treatment. The goal was to see if SYN023 works as well as the c…

This study tested a new rabies vaccine (VRVg-2) in over 1,700 healthy children and adults in Thailand. The goal was to see if it works as well as current rabies vaccines when given before exposure to the virus. Participants received three doses, and some got a booster shot later …

This study surveyed 214 Egyptian doctors to see how well they follow official guidelines for preventing rabies after an animal bite. The researchers used 10 case scenarios to score each doctor's knowledge. The goal is to find where doctors may need more training, which could redu…